Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus

Pereira, M and Gohin, S and Lund, N and Hvid, A and Smitham, P J and Oddy, M J and Reichert, I and Farley, D and Roux, J P and Cleasby, M E and Chenu, C (2017) Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus. OSTEOPOROSIS INTERNATIONAL, 28 (1). pp. 309-320.

[img]
Preview
Text
10599.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (958kB) | Preview

Actions (Repository Editors)

View Item View Item